The use of drugs in mothers of offspring with neural-tube defects

Erika Medveczky, E. Puhó, E. Czeizel

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Objective. To study the risk of maternal drugs use during pregnancy in the origin of isolated neural-tube defects (NTD). Materials and methods. 1202 cases with NTD, 38 151 population controls without any defects and 22475 patient controls with other defects were compared in the population-based data set of the Hungarian Case-Control Surveillance of Congenital Abnormalities (HCCSCA), 1980-1996. The HCCSCA contains 542 drugs, however only those drugs were evaluated which included five or more mothers in the NTD group. Drugs with the same chemical structures were combined. In addition, only drug use in the second month of pregnancy was evaluated because it is the critical period for NTD. Of course, it is necessary to exclude different biases, mainly recall bias at the evaluation of these drugs. Of 121 chemicals, only oxytetracycline, carbamazepine and valproic acid had some association with NTD. High doses of exogenous oestrogens, clomiphene, chorionic gonadotropin, lynesterol and ergotamine also seemed to have some indirect association with NTD because their exposures occurred more frequently before the critical period of NTD due to maternal infertility. Conclusion. Our findings suggest that drugs used during pregnancy do not appear to substantially contribute to the occurrence of isolated NTD but some drugs have a role in the origin of these defects.

Original languageEnglish
Pages (from-to)443-455
Number of pages13
JournalPharmacoepidemiology and Drug Safety
Volume13
Issue number7
DOIs
Publication statusPublished - Jul 2004

Fingerprint

Neural Tube Defects
Mothers
Pharmaceutical Preparations
Pregnancy
Ergotamine
Oxytetracycline
Clomiphene
Drug Evaluation
Population Control
Carbamazepine
Valproic Acid
Chorionic Gonadotropin
Infertility
Estrogens

Keywords

  • Carbamazepine
  • Human teratogenic potential
  • Maternal drug use
  • Neural-tube defects
  • Oxytetracycline
  • Recall bias
  • Valproic acid

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

The use of drugs in mothers of offspring with neural-tube defects. / Medveczky, Erika; Puhó, E.; Czeizel, E.

In: Pharmacoepidemiology and Drug Safety, Vol. 13, No. 7, 07.2004, p. 443-455.

Research output: Contribution to journalArticle

@article{caf93b8a185a4eb687b01ee42fcdbbce,
title = "The use of drugs in mothers of offspring with neural-tube defects",
abstract = "Objective. To study the risk of maternal drugs use during pregnancy in the origin of isolated neural-tube defects (NTD). Materials and methods. 1202 cases with NTD, 38 151 population controls without any defects and 22475 patient controls with other defects were compared in the population-based data set of the Hungarian Case-Control Surveillance of Congenital Abnormalities (HCCSCA), 1980-1996. The HCCSCA contains 542 drugs, however only those drugs were evaluated which included five or more mothers in the NTD group. Drugs with the same chemical structures were combined. In addition, only drug use in the second month of pregnancy was evaluated because it is the critical period for NTD. Of course, it is necessary to exclude different biases, mainly recall bias at the evaluation of these drugs. Of 121 chemicals, only oxytetracycline, carbamazepine and valproic acid had some association with NTD. High doses of exogenous oestrogens, clomiphene, chorionic gonadotropin, lynesterol and ergotamine also seemed to have some indirect association with NTD because their exposures occurred more frequently before the critical period of NTD due to maternal infertility. Conclusion. Our findings suggest that drugs used during pregnancy do not appear to substantially contribute to the occurrence of isolated NTD but some drugs have a role in the origin of these defects.",
keywords = "Carbamazepine, Human teratogenic potential, Maternal drug use, Neural-tube defects, Oxytetracycline, Recall bias, Valproic acid",
author = "Erika Medveczky and E. Puh{\'o} and E. Czeizel",
year = "2004",
month = "7",
doi = "10.1002/pds.900",
language = "English",
volume = "13",
pages = "443--455",
journal = "Pharmacoepidemiology and Drug Safety",
issn = "1053-8569",
publisher = "John Wiley and Sons Ltd",
number = "7",

}

TY - JOUR

T1 - The use of drugs in mothers of offspring with neural-tube defects

AU - Medveczky, Erika

AU - Puhó, E.

AU - Czeizel, E.

PY - 2004/7

Y1 - 2004/7

N2 - Objective. To study the risk of maternal drugs use during pregnancy in the origin of isolated neural-tube defects (NTD). Materials and methods. 1202 cases with NTD, 38 151 population controls without any defects and 22475 patient controls with other defects were compared in the population-based data set of the Hungarian Case-Control Surveillance of Congenital Abnormalities (HCCSCA), 1980-1996. The HCCSCA contains 542 drugs, however only those drugs were evaluated which included five or more mothers in the NTD group. Drugs with the same chemical structures were combined. In addition, only drug use in the second month of pregnancy was evaluated because it is the critical period for NTD. Of course, it is necessary to exclude different biases, mainly recall bias at the evaluation of these drugs. Of 121 chemicals, only oxytetracycline, carbamazepine and valproic acid had some association with NTD. High doses of exogenous oestrogens, clomiphene, chorionic gonadotropin, lynesterol and ergotamine also seemed to have some indirect association with NTD because their exposures occurred more frequently before the critical period of NTD due to maternal infertility. Conclusion. Our findings suggest that drugs used during pregnancy do not appear to substantially contribute to the occurrence of isolated NTD but some drugs have a role in the origin of these defects.

AB - Objective. To study the risk of maternal drugs use during pregnancy in the origin of isolated neural-tube defects (NTD). Materials and methods. 1202 cases with NTD, 38 151 population controls without any defects and 22475 patient controls with other defects were compared in the population-based data set of the Hungarian Case-Control Surveillance of Congenital Abnormalities (HCCSCA), 1980-1996. The HCCSCA contains 542 drugs, however only those drugs were evaluated which included five or more mothers in the NTD group. Drugs with the same chemical structures were combined. In addition, only drug use in the second month of pregnancy was evaluated because it is the critical period for NTD. Of course, it is necessary to exclude different biases, mainly recall bias at the evaluation of these drugs. Of 121 chemicals, only oxytetracycline, carbamazepine and valproic acid had some association with NTD. High doses of exogenous oestrogens, clomiphene, chorionic gonadotropin, lynesterol and ergotamine also seemed to have some indirect association with NTD because their exposures occurred more frequently before the critical period of NTD due to maternal infertility. Conclusion. Our findings suggest that drugs used during pregnancy do not appear to substantially contribute to the occurrence of isolated NTD but some drugs have a role in the origin of these defects.

KW - Carbamazepine

KW - Human teratogenic potential

KW - Maternal drug use

KW - Neural-tube defects

KW - Oxytetracycline

KW - Recall bias

KW - Valproic acid

UR - http://www.scopus.com/inward/record.url?scp=3242892579&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3242892579&partnerID=8YFLogxK

U2 - 10.1002/pds.900

DO - 10.1002/pds.900

M3 - Article

VL - 13

SP - 443

EP - 455

JO - Pharmacoepidemiology and Drug Safety

JF - Pharmacoepidemiology and Drug Safety

SN - 1053-8569

IS - 7

ER -